Endogenous Erythroid Colony Formation in Chronic Myeloid Leukemia: A Recurrent Finding Associated with Persistent Minimal Residual Disease Under Imatinib-Reference-Cited by-同舟云学术

Endogenous Erythroid Colony Formation in Chronic Myeloid Leukemia: A Recurrent Finding Associated with Persistent Minimal Residual Disease Under Imatinib

Published:2013-12 Issue:23 Volume:22 Page:3043-3051
ISSN:1547-3287
Container-title:Stem Cells and Development
language:en
Short-container-title:Stem Cells and Development

Author:

Einwallner Elisa¹,Jaeger Eva¹,Mitterbauer-Hohendanner Gerlinde¹,Bilban Martin¹,Simonitsch-Klupp Ingrid²,Steiner Irene³,Pernicka Elisabeth³,Hoermann Gregor¹,Herndlhofer Susanne⁴,Sillaber Christian⁴,Valent Peter⁴,Schwarzinger Ilse¹

Affiliation:

1. Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.

2. Clinical Institute of Pathology, Medical University of Vienna, Vienna, Austria.

3. Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

4. Division of Hematology and Hemostaseology and Ludwig Boltzmann Cluster Oncology, Department of Internal Medicine I, Medical University of Vienna, Vienna, Austria.

Publisher

Mary Ann Liebert Inc

Subject

Cell Biology,Developmental Biology,Hematology

Link

https://www.liebertpub.com/doi/pdf/10.1089/scd.2013.0096

Reference45 articles.

1. Influence of the Assays of Endogenous Colony Formation and Serum Erythropoietin on the Diagnosis of Polycythemia Vera and Essential Thrombocythemia

2. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms

3. Endogenous Erythroid Colony Formation by Peripheral Blood Mononuclear Cells from Patients with Myelofibrosis and Polycythemia Vera

4. Chromosome analysis of isolated colony erythroblasts in chronic myelogenous leukaemia

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenretinide targets the side population in myeloma cell line NCI-H929 and potentiates the efficacy of antimyeloma with bortezomib and dexamethasone regimen;Leukemia Research;2016-12